New Molecular Entities Approved In 2011
This article was originally published in Pharmaceutical Approvals Monthly
You may also be interested in...
FDA Sets A Fast Pace Of Novel Approvals In First Half, But That's Likely To Slow
A sparsely populated user fee calendar for the remainder of 2011 likely precludes a repeat of FDA’s stunning approval performance in the first half of this year. Still, with 20 approvals of new molecular entities and novel biologics during those first six months, the agency is all but assured of one of its best years in a decade – at the least.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.